These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 17541959

  • 1. The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population.
    Heer R, Robson CN, Shenton BK, Leung HY.
    J Cell Physiol; 2007 Sep; 212(3):572-8. PubMed ID: 17541959
    [Abstract] [Full Text] [Related]

  • 2. Hunterian Lecture. Characterisation of human prostate epithelial progenitor differentiation in response to androgens.
    Heer R.
    Ann R Coll Surg Engl; 2011 Sep; 93(6):424-8. PubMed ID: 21929909
    [Abstract] [Full Text] [Related]

  • 3. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
    Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S.
    Prostate; 2005 Dec 01; 65(4):287-98. PubMed ID: 16015608
    [Abstract] [Full Text] [Related]

  • 4. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
    Williamson SC, Hepburn AC, Wilson L, Coffey K, Ryan-Munden CA, Pal D, Leung HY, Robson CN, Heer R.
    PLoS One; 2012 Dec 01; 7(11):e48944. PubMed ID: 23145034
    [Abstract] [Full Text] [Related]

  • 5. KGF suppresses alpha2beta1 integrin function and promotes differentiation of the transient amplifying population in human prostatic epithelium.
    Heer R, Collins AT, Robson CN, Shenton BK, Leung HY.
    J Cell Sci; 2006 Apr 01; 119(Pt 7):1416-24. PubMed ID: 16554439
    [Abstract] [Full Text] [Related]

  • 6. Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies.
    Lin H, Lu JP, Laflamme P, Qiao S, Shayegan B, Bryskin I, Monardo L, Wilson BC, Singh G, Pinthus JH.
    Int J Oncol; 2010 Oct 01; 37(4):761-6. PubMed ID: 20811696
    [Abstract] [Full Text] [Related]

  • 7. Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.
    Zhang Y, Won SH, Jiang C, Lee HJ, Jeong SJ, Lee EO, Zhang J, Ye M, Kim SH, Lü J.
    Pharm Res; 2012 Jun 01; 29(6):1595-608. PubMed ID: 22281759
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effect of the antiandrogen apalutamide (ARN-509) versus bicalutamide on the androgen receptor pathway in prostate cancer cell lines.
    Koukourakis MI, Kakouratos C, Kalamida D, Mitrakas A, Pouliliou S, Xanthopoulou E, Papadopoulou E, Fasoulaki V, Giatromanolaki A.
    Anticancer Drugs; 2018 Apr 01; 29(4):323-333. PubMed ID: 29381490
    [Abstract] [Full Text] [Related]

  • 9. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
    Cherian MT, Wilson EM, Shapiro DJ.
    J Biol Chem; 2012 Jul 06; 287(28):23368-80. PubMed ID: 22589544
    [Abstract] [Full Text] [Related]

  • 10. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
    Sadar MD, Gleave ME.
    Cancer Res; 2000 Oct 15; 60(20):5825-31. PubMed ID: 11059779
    [Abstract] [Full Text] [Related]

  • 11. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
    Culig Z, Hoffmann J, Erdel M, Eder IE, Hobisch A, Hittmair A, Bartsch G, Utermann G, Schneider MR, Parczyk K, Klocker H.
    Br J Cancer; 1999 Sep 15; 81(2):242-51. PubMed ID: 10496349
    [Abstract] [Full Text] [Related]

  • 12. Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells.
    Segal CV, Koufaris C, Powell C, Gooderham NJ.
    Toxicology; 2015 Jul 03; 333():45-52. PubMed ID: 25846647
    [Abstract] [Full Text] [Related]

  • 13. Neither fibroblast growth factor-1 nor fibroblast growth factor-2 is an androgen receptor coactivator in androgen-resistant prostate cancer.
    Shain SA.
    Mol Urol; 2001 Jul 03; 5(3):121-30. PubMed ID: 11690559
    [Abstract] [Full Text] [Related]

  • 14. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G.
    Cancer Res; 1997 Mar 15; 57(6):1086-90. PubMed ID: 9067276
    [Abstract] [Full Text] [Related]

  • 15. Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A.
    Desiniotis A, Schäfer G, Klocker H, Eder IE.
    Int J Cancer; 2010 Feb 01; 126(3):775-89. PubMed ID: 19653278
    [Abstract] [Full Text] [Related]

  • 16. Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.
    Dondoo TO, Fukumori T, Daizumoto K, Fukawa T, Kohzuki M, Kowada M, Kusuhara Y, Mori H, Nakatsuji H, Takahashi M, Kanayama HO.
    Anticancer Res; 2017 Jan 01; 37(1):125-134. PubMed ID: 28011482
    [Abstract] [Full Text] [Related]

  • 17. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y, Liu G, Tong D, Parmar H, Hasenmayer D, Yuan W, Zhang D, Jiang J.
    Prostate; 2015 Aug 01; 75(11):1187-96. PubMed ID: 25894097
    [Abstract] [Full Text] [Related]

  • 18. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H.
    Cancer Res; 1994 Oct 15; 54(20):5474-8. PubMed ID: 7522959
    [Abstract] [Full Text] [Related]

  • 19. Quantum dots-based multiplexed immunohistochemistry of protein expression in human prostate cancer cells.
    Shi C, Zhou G, Zhu Y, Su Y, Cheng T, Zhau HE, Chung LW.
    Eur J Histochem; 2008 Oct 15; 52(2):127-34. PubMed ID: 18591159
    [Abstract] [Full Text] [Related]

  • 20. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
    Chuu CP, Kokontis JM, Hiipakka RA, Fukuchi J, Lin HP, Lin CY, Huo C, Su LC, Liao S.
    Cancer Sci; 2011 Nov 15; 102(11):2022-8. PubMed ID: 21781227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.